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1. Introduction  
Anemia is considered to be one of the major health problems. According to the World 
Health Organization, about 30 percent of people throughout the world suffer from anemia. 
The most common cause of anemia is iron deficiency; however, recent work has shown that 
reactive oxygen species (ROS) of erythrocytes are one of the principal causative factors of 
anemia. Elevation of ROS in erythrocytes could occur either by activation of ROS generation 
or by suppression of antioxidative/redox system. When erythrocytes experience an 
excessive elevation of ROS, oxidative stress develops. ROS are known to contribute to the 
pathogenesis of several hereditary disorders of erythrocytes, including sickle cell anemia, 
thalassemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency. 
Deficiency of antioxidant enzymes such as superoxide dismutase 1 (SOD1) or peroxiredoxin 
II (Prx II) induces elevation of oxidative stress in erythrocytes and causes anemia, while 
deficiency of catalase or glutathione peroxidase does not. In addition to the abnormalities of 
antioxidant enzymes, some transcription factors such as p45NF-E2 or Nrf2 can cause 
anemia. In this chapter, I provide some evidence of the involvement of oxidative stress in 
anemia. 
2. Oxidative stress-mediated destruction of erythrocytes 
2.1 Cellular oxidative stress and anti-oxidative system 
Under normal physiological conditions, there is a balance between the ROS and the defense 
system of antioxidant enzymes and antioxidants, which prevents or limits oxidative 
damage. ROS are produced as a result of intracellular metabolic activity. During this 
process, ROS such as superoxide (O2-), hydrogen peroxide (H2O2), and hydroxyl radical 
(OH) are produced, even in healthy individuals. Oxidative stress is the result of an 
imbalance between oxidants and antioxidants. Increased pro-oxidants and/or decreased 
antioxidants trigger a cascade of oxidative reactions. Oxidative stress can damage specific 
molecular targets (lipids, proteins, nucleotides, etc.), resulting in cell dysfunction and/or 
death. Enzymes that participate in ROS production include xanthine oxidase (XO), 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, nitric oxide synthase 
(NOS), cytochrome P450, cyclo-oxygenase (COX), and lipoxygenase. Major defence 
mechanisms against ROS include enzymatic (superoxide dismutase (SOD), catalase, 
glutathione peroxidase (GPx), peroxiredoxin (Prx)) as well as non-enzymatic systems 
(reduced glutathione (GSH), ubiquinols, uric acid, vitamins C and E, flavonoids, 
carotenoids). 
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Fig. 1. Reactive oxygen species (ROS) generated in the cell. 
2.2 Oxidation of erythrocyte membrane caused by ROS 
During the binding of oxygen to form oxy-hemoglobin (oxy-Hb), one electron is transferred 
from iron to the bound oxygen forming a ferric-superoxide anion complex. The shared 
electron is normally returned to the iron when oxygen is released during deoxygenation. 
However, the electrons can remain and transform oxygen into superoxide anions. In this 
process, iron is left in the ferric state and Hb is transformed into methemoglobin (met-Hb). 
The autoxidation of Hb occurs spontaneously and transforms 0.5–3% of Hb into met-Hb per 
day. In addition to this physiological process, met-Hb can be produced by endogenous 
oxidants, such as H2O2, nitric oxide (NO), and hydroxyl radicals. Since met-Hb cannot bind 
oxygen, this is the first step in the formation of harmful hemichromes (Rice-Evans & Baysal, 
1987). In normal conditions, spontaneous production of met-Hb from autoxidation and 
conversion of met-Hb back to Hb are in balance. However, in pathological conditions, 
increased oxidative stress or impaired antioxidant defence will enhance production of met-
Hb and generation of ROS. Hemichrome formation depends on the amount of met-Hb 
formed and is accelerated by ROS such as superoxide or H2O2. Superoxide produced by one 
electron reduction of oxygen would reduce ferri-hemichrome to ferro-hemichrome. In the 
Fenton reaction, ferro-hemichrome catalyzes decomposition of H2O2 to hydroxyl radical. 
Hydroxyl radical is an extremely reactive free radical that can react with various 
biomolecules such as membrane lipids. Peroxidation of membrane lipids, most notably the 
polyunsaturated fatty acids arachidonic acid and linoleic acid, generates a wide array of 
molecules, such as lipid hydroperoxides, which are secondary lipid peroxidation products 
(for example, malondialdehyde and 4-hydroxynonenal, HNE). Lipid peroxidation products 
can damage membrane structure with the formation of membrane pores, alter water 
permeability, decrease cell deformability, and enhance IgG binding and complement 
activation. Finally, disruption of the normal asymmetrical distribution of membrane 
phospholipids occurs. This may enhance exposure of phosphatidylserine (PS) on the outer 
cell surface. Erythrocytes that have PS exposed on the outer surface are recognized and 
engulfed by macrophages with PS-specific receptors, resulting in their degradation (Carrell 
et al., 1975; Hebbel, 1985; Nur et al., 2011).  
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At the same time, ROS can be used for killing harmful microorganisms. However, ROS not 
only participate in pathogen killing but also induce activation of inflammatory mediators 
and production of adhesion molecules and membrane damage. The increased intra- and 
extra-erythrocytic oxidative stress induces lipid peroxidation and membrane instability, 
contributing to accelerated hemolysis. Increased levels of hydroperoxides cause erythrocyte 
membrane damage and deformity and, ultimately, lead to cell death. 
2.3 Band 3-mediated erythrocyte removal 
Band 3, also termed the anion exchanger, is a major erythrocyte membrane protein, 
constituting 25% of the total erythrocyte membrane protein. It has two independent 
domains: the membrane-spanning domain, which catalyzes anion exchange and contains 
the antigenic determinants recognized by naturally occurring antibodies (NAbs), and the 
cytoplasmic domain (Pantaleo et al., 2008). A very important feature of hemichrome/free 
heme/iron damage is its non-random occurrence in space. The highly damaging feature of 
hemichromes is their tight association with the cytoplasmic domain of band 3, which, 
following their binding, leads to band 3 oxidation and clusterization. These band 3 clusters 
show increased affinity for NAbs, which activate complement and finally trigger 
phagocytosis-mediated erythrocyte removal. This band 3/hemichrome complex was found 
not only in pathological conditions in which oxidative stress in erythrocytes is thought to be 
elevated, but also in senescent erythrocytes (Arese et al., 2005). 
3. Relationship between human hereditary anemia and oxidative stress 
3.1 Sickle cell disease 
Sickle cell disease (SCD) is a hemoglobinopathy clinically characterized by chronic 
hemolysis. Chronic activation and damage of endothelial cells by sickle erythrocytes, heme, 
polymorphonuclear neutrophils (PMNs), and inflammatory mediators contribute to 
progressive microvascular damage in all organs, including the brain, lungs, and kidneys. 
SCD is an inherited disorder of hemoglobin synthesis. SCD has the same single base pair 
mutation (GAG to GTG, Glu to Val) in the ǃglobin molecule of sickle cells (HbS). 
Chronic oxidative stress constitutes a critical factor in endothelial dysfunction, 
inflammation, and multiple organ damage in SCD (Nur et al., 2011). There are several 
causes of oxidative stress in SCD. Major sources of ROS in SCD are thought to be the (i) 
enhanced rate of HbS auto-oxidation, (ii) increased xanthine oxidase activity in SCD aortic 
endothelium, and (iii) higher number of leucocytes, which produce twice the fluxes of 
superoxide in SCD (Wood & Granger, 2007). 
Endothelial dysfunction in patients with SCD has been related to inflammation, high 
levels of production of ROS and reactive nitrogen species, and erythrocyte adhesion to 
blood vessel walls. There have been several studies showing that patients with SCD have 
a high level of oxidative damage, assessed through lipid peroxidation. In turn, oxidative 
stress is associated with chronic hemolysis. Sickle erythrocytes have a high frequency of 
phosphatidyl serine exposure, which is due to oxidative stress, suggesting that oxidative 
stress might play a role in intravascular hemolysis. Hypertension in patients with SCD 
was found to be related to ROS, which can directly deactivate endothelial nitric oxide 
synthase (eNOS), reducing nitric oxide (NO) levels, an important vasodilator (Rusanova 
et al., 2010). 
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3.2 Thalassemia 
The thalassemia syndrome is one of the most common genetic disorders affecting a single 
gene or gene cluster. The various thalassemia disorders are caused by insufficient 
production of one of the two types of globin chains that constitute the hemoglobin tetramer. 
In ǂ thalassemia , ǂglobin production is reduced or absent, and in ǃthalassemia, ǃglobin 
production is impaired. The ǂand ǃthalassemias are characterized by the presence of a 
pool of unpaired hemoglobin chains. While ǂorǃhemoglobin chains are stable when part 
of the ǂ2ǃ2 hemoglobin tetramer, the unpaired ǂ or ǃhemoglobin chains are unstable and 
subject to high rates of auto-oxidation. The auto-oxidation of the unpaired hemoglobin 
chains leads to the generation of superoxide and H2O2, and subsequent release of globin-free 
heme and iron (Bunn, 1967; Shinar & Rachmilewitz, 1990). ǃthalassemic erythrocytes 
exhibit a significant decrease in the NADPH/NADP ratio similar to that seen in severe 
G6PD-deficiency anemia (see next chapter). As a consequence of this decrease, both catalase 
activity and GSH concentration are decreased (Scot, 2006). Expression of peroxiredoxin (Prx) 
II, an antioxidant enzyme that detoxifies H2O2, is increased in ǃthalassemic mouse 
erythrocytes (Matte et al., 2010). These findings indicate that this high expression of PrxII 
has a compensatory effect against elevated oxidative stress in thalassemic erythrocytes 
(Rund & Rachmilewitz, 2005). 
3.3 Glucose-6-phosphate dehydrogenase (G6PD) deficiency 
Glucose-6-phosphate dehydrogenase (G6PD) deficiency was first discovered in African-
American subjects. The fact that it seemed to be limited to one ethnic group suggested that it 
has a genetic basis. Because it was shown that transmission was generally from mother to son, 
it became apparent that G6PD deficiency is an X-linked disorder. G6PD deficiency is one of the 
glycolytic enzymopathies that frequently cause hemolytic anemia. G6PD deficiency is the most 
common erythrocyte enzyme defect, affecting over 400 million people (Beutler, 2008).  
G6PD deficiency is mainly caused by point mutations in the G6PD gene. About 140 
mutations have been described: most are single base changes, leading to amino acid 
substitutions (Cappellini & Fiorelli, 2008). The most frequent clinical manifestations of G6PD 
deficiency are neonatal jaundice and acute hemolytic anemia, which is usually triggered by 
an exogenous agent. Some G6PD variants cause chronic hemolysis, leading to congenital 
non-spherocytic hemolytic anemia. The appearance of Heinz bodies both in vivo and in 
vitro in G6PD-deficient cells and their inability to protect their GSH against drug challenge 
suggested that a major component of the hemolytic process is the inability of the 
erythrocytes to protect sulfhydryl groups against oxidative stress (Fig. 2, Cohen & 
Hochstein, 1961). However, it has been shown that, in mice, targeted disruption of the gene 
encoding glutathione peroxidase has little effect on oxidation of hemoglobin of murine cells 
challenged with peroxides. 
G6PD provides erythrocytes with important protection against oxidative stress. G6PD is a 
key regulatory enzyme of the pentose phosphate pathway (also called hexose 
monophosphate shunt), which is essential for the supply of reduced NADPH. NADPH 
enables cells to counterbalance oxidative stress that can be triggered by several oxidant 
agents, and to preserve the reduced form of glutathione. NADPH is pivotal to the cellular 
antioxidative defence systems in most organisms. Since erythrocytes do not contain 
mitochondria, the pentose phosphate pathway is their only source of NADPH; therefore, 
defence against oxidative damage is dependent on G6PD. 
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Fig. 2. Percentage change in reduced glutathione (GSH) in erythrocytes of 13 individuals 
with G6PD deficiency (solid circles) and 13 individuals with normal G6PD activity (open 
circles) after 3 hours of hydrogen peroxide diffusion (Cohen & Hochstein, 1961). 
4. Animal model of anemia 
4.1 Deficiency of antioxidant enzymes 
4.1.1 Superoxide dismutase 1 (SOD1) deficiency 
Among the known antioxidative proteins, superoxide dismutase (SOD) is thought to play a 
central role because of its ability to scavenge superoxide anions, the primary ROS generated 
from molecular oxygen in cells (Fridovich, 1995). SOD1-deficient mice have been generated 
by several groups. Unexpectedly, SOD1-deficient mice grow normally but develop female 
infertility (Ho et al., 1998; Matzuk et al., 1998), cochlear hair cell loss (McFadden et al., 1999), 
and vascular dysfunction (Didion et al., 2002). Adding to these phenotypes, SOD1-deficient 
mice exhibit severe anemia, even in infant mice (Iuchi et al., 2007; Starzyński et al., 2009). 
Anemia appears to be caused by shortened lifespan of erythrocytes. Increased ROS due to 
SOD1 deficiency makes their erythrocytes vulnerable to oxidative stress. In addition to 
SOD1 deficiency, GPx activity and protein levels of GPx1 were significantly lower in 
erythrocytes. Since GPx1 protein is prone to oxidative inactivation, oxidized GPx1 would be 
removed by the protease that degrades oxidized proteins in erythrocytes. 
While most mammalian cells possess two intracellular SOD isoforms to protect against ROS, 
erythrocytes lack mitochondria and, as a result, carry only the SOD1 protein to scavenge 
superoxide anions. Erythrocytes of SOD1-deficient mice, therefore, face severe oxygen 
toxicity compared with other tissues. Erythrocytes that are hyperoxic bind oxygen in the 
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lungs (∼21%), and release oxygen in peripheral tissues, which are relatively hypoxic (∼2%). 
Thus, erythrocytes undergo cyclic exposure to hyperoxic and hypoxic environments, 
generating large amounts of superoxide via auto-oxidation of hemoglobin.  
The continuous destruction of oxidized erythrocytes in SOD1-deficient mice appears to 
induce the formation of autoantibodies against certain erythrocyte components, for 
example, carbonic anhydrase II, and the immune complex is deposited in the kidney 
glomeruli. Therefore, these mice exhibit autoimmune hemolytic anemia (AIHA)-like 
symptoms when they reach old age. This pathophysiological symptom is thought as a 
secondary effect of elevated oxidative stress in SOD1-deficient erythrocytes. 
 
 
Fig. 3. Elevated ROS (left panels) and shortened lifespan (right panel) of erythrocytes in 
SOD1-deficient mice (Iuchi et al., 2007). 
4.1.2 Catalase deficiency 
Human erythrocytes contain large amounts of catalase. While the catalase and 
NADPH/GSH/GPx system is very important for disposal of H2O2 in human erythrocytes, 
genetic deficiencies of catalase do not predispose erythrocytes to peroxide-induced 
destruction (Jacob et al., 1965). Mice lacking the catalase gene develop normally (Ho et al., 
2004). A link between catalase deficiency and anemia has not been reported. 
4.1.3 Glutathione peroxidase-1 (GPx1) deficiency 
The role of glutathione peroxidase in erythrocyte anti-oxidant defense was examined using 
erythrocytes from mice with genetically engineered disruption of the glutathione peroxidase-1 
(GPx1) gene. Because GPx1 is the sole glutathione peroxidase in erythrocytes, all erythrocyte 
GSH peroxidase activity was eliminated. Oxidation of hemoglobin and membrane lipids was 
determined during oxidant challenge from cumene hydroperoxide and H2O2. As a result, no 
difference was detected between wild-type erythrocytes and GPx1–deficient erythrocytes, 
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even at high levels of H2O2 exposure. Thus, GPx1 appears to play little or no role in the 
defense of erythrocytes against exposure to peroxide (Johnson et al., 2000). 
 
 
Fig. 4. Do SOD1 and PrxII actually work in erythrocytes? 
4.1.4 Peroxiredoxin II (PrxII) deficiency 
A number of proteins also protect cells against oxidative stress. SOD, GPx, and catalase are 
commonly known antioxidant enzymes and have been extensively characterized. Recently, 
a new family of antioxidative proteins, collectively referred to as Prxs (peroxiredoxins), have 
been identified. Six distinct gene products are known in the Prx family in mammals (Fujii & 
Ikeda, 2002). Thioredoxin-dependent peroxidase activity appears to be common to most Prx 
family members, and in addition, other divergent biological functions have been elucidated 
for individual Prx members. However, the most well-characterized function of Prx family 
members is the ability to modulate hydrogen peroxide signaling in response to various 
stimuli (Rhee et al., 2005). 
Mice deficient in Prx II, which is abundantly expressed in all types of cells, were healthy in 
appearance and fertile. However, they had splenomegaly caused by the congestion of red 
pulp with hemosiderin accumulation. Erythrocytes from these mice contained markedly 
higher levels of ROS. The Prx II-deficient mice had significantly decreased hematocrit levels, 
but increased reticulocyte counts and erythropoietin levels, indicative of a compensatory 
action to maintain hematologic homeostasis in the mice (Lee et al., 2003).  
For a long time, it was considered that catalase and GPx constitute the erythrocyte defense 
against H2O2, and there has been continuous debate about which of these is more significant 
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(Cohen & Hochstein, 1963; Gaetani et al., 1989; Gaetani et al., 1996). Until recently, little 
attention has been paid to the antioxidant role of Prxs in erythrocytes, even though Prx II is 
the third most abundant cytoplasmic erythrocyte protein. These mice possess fully 
functional catalase and GPx. Erythrocytes also possess PrxI and PrxVI, although at lower 
levels than PrxII. It is reported that PrxII expression and content were markedly increased in 
erythrocytes from ǃthalassemic mouse models compared with those in wild-type mice 
(Matte et al., 2010). This indicates that PrxII has a non-redundant function in protecting 
healthy erythrocytes against oxidative damage and plays a crucial role even in pathological 
conditions. 
4.2 Deficiency of transcription factor 
In many cases, transcriptional activation of genes that play an important role in 
detoxification of xenobiotics and defense against oxidative stress is mediated partly by the 
antioxidant response element (ARE). For example, AREs have been found in promoter 
sequences of genes including nicotinamide adenine dinucleotide phosphate–quinone 
oxidoreductase, heme oxygenase, glutathione-S-transferases, and glutamylcysteine 
synthetase (Favreau et al., 1995; Inamdar et al., 1996; Jaiswal et al., 1994; Mulcahy et al., 1995; 
Prestera et al., 1995). The ARE consensus sequence is very similar to the NF-E2–like 
sequence of the ǃ globin locus control region, which was found to be essential for globin 
gene expression. Multiple proteins can interact with the NF-E2 consensus sequence. The cap 
‘n’ collar (CNC)–bZIP factor family of proteins was identified from searches for proteins that 
bind and activate the NF-E2 site of the ǃ-globin locus control region. This multiple-protein 
family includes p45NF-E2, NF-E2–related factor (Nrf)1, and Nrf2. The similarities among 
CNC family members are most notable in the basic-DNA binding region and another 
homology domain (Moi et al., 1994).  
4.2.1 p45NF-E2 deficiency 
p45NF-E2 is a member of the cap ‘n’ collar (CNC)-basic leucine zipper family of 
transcriptional activators that is expressed at high levels in various types of blood cells. It 
plays a crucial role in megakaryocyte maturation and platelet biogenesis. Mice with 
disruption of p45NF-E2 have severe platelet deficiency due to defective megakaryocyte 
maturation. In addition, p45NF-E2 knockout mice exhibit anemia characterized by the 
presence of hypochromic erythrocytes and reticulocytosis. Erythrocytes from p45NF-E2–
deficient mice are sensitive to oxidative stress. Erythrocytes from p45NF-E2–deficient mice 
accumulated high levels of free radicals when exposed to oxidants, and this correlated with 
increased formation of met-Hb and loss of membrane deformability. In addition, severe 
anemia developed in p45NF-E2 deficient mice treated with oxidative-stress–inducing drugs, 
and mutant erythrocytes had decreased survival. 
Because CNC factors may represent an important class of regulators of antioxidant gene 
expression by means of the ARE, one possibility is that p45NF-E2 is involved in regulating 
oxidative stress-response genes in erythrocytes. It is possible that a compensated hemolytic 
state contributes to the erythroid abnormalities observed in p45NF-E2 knockout mice. 
4.2.2 Nrf2 deficiency 
The NF-E2-related factor 2 (Nrf2) transcription factor regulates genes related to ROS 
scavenging and detoxification. Although Nrf2 is expressed widely and is important for cellular 
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antioxidant potential, Nrf2 knockout mice develop and grow normally (Chan et al., 1996). 
Young Nrf2 knockout mice are not anemic, whereas targeted disruption of either NF-E2 or 
Nrf1 resulted in anemia. In aged mice, however, disruption of Nrf2 causes regenerative 
immune-mediated hemolytic anemia due to increased sequestration of damaged erythrocytes. 
Splenomegaly and spleen toxicity in Nrf2-deficient mice raised the possibility of hemolytic 
anemia and splenic extramedullary hematopoiesis in Nrf2-deficient mice. Nrf2-deficient 
erythrocytes are highly sensitive to H2O2-induced hemolysis in vitro, further suggesting that 
Nrf2-deficient erythrocytes are highly susceptible to stress. In addition, Nrf2-deficient 
erythrocytes showed increased met-Hb formation after incubation with high concentrations of 
H2O2, suggesting that Hb in Nrf2-deficient erythrocytes is more easily oxidized than that in 
Nrf2 WT erythrocytes (Lee et al., 2004). A unique feature of the Nrf2-ARE pathway (the 
programmed cell life pathway) (Li et al., 2002) is that it coordinately up-regulates many 
protective detoxification and antioxidant genes, which can synergistically increase the 
efficiency of the erythrocyte defense system against oxidative stress. 
4.2.3 Nrf1 deficiency 
Nrf1 knockout mice have also been reported to develop anemia in early stages of embryo, 
and they die in utero (Chan et al., 1998). Nrf1 knockout mice have abnormal fetal liver 
erythropoiesis as a result of a defect in the fetal liver microenvironment specific for 
erythroid cells. Anemic phenotype of Nrf1-deficient mice is not due to the oxidative stress in 
erythrocytes, but due to abnormal erythropoiesis. 
5. Relationship between hereditary sideroblastic anemia and SOD2
 
deficiency 
5.1 Hereditary sideroblastic anemia 
Iron overload is a feature of human disorders including sideroblastic anemia (SA). Excess iron 
is toxic because it can catalyze the generation of ROS that damage cellular molecules. Some 
genetic lesions have been identified as causes of hereditary or acquired SA. As defined genetic 
lesions, dysfunction in one of the mitochondrial metabolic pathways has been observed: heme 
synthesis, iron homeostasis and transport, or electron transport. These lesions result in 
abnormal use of erythroid mitochondrial iron, causing pathologic iron deposition (Napier et 
al., 2005). Identified lesions affect nuclear-encoded mitochondrial proteins or the 
mitochondrial genome. The heme biosynthetic pathway was identified as a primary cause of 
SA. However, other pathways, including mitochondrial oxidative phosphorylation and iron–
sulfur cluster biosynthesis, were also identified as primary defects in SAs. They may 
secondarily affect heme metabolism (Rouault & Tong, 2005; Martin, 2006). Two X-linked 
sideroblastic anemias (XLSAs) exist, one caused by mutations of an erythroid-specific form of 
the heme biosynthetic enzyme aminolevulinic acid (ALA)–synthase 2 (ALAS2) (Cotter et al., 
1994), and one caused by mutation of a putative mitochondrial iron-transport protein, ATP-
binding cassette, member 7 (ABC7) (Allikmets et al., 1999). 
5.2 SOD2-deficiency anemia 
SOD2-deficiency anemia is another example of mitochondrial dysfunction resulting in an 
erythroid-specific SA-like phenotype. Although genetically deficient mice of SOD1 have a 
normal lifespan along with exhibiting an anemic phenotype (Iuchi et al., 2007), inactivation 
of SOD2 results in embryonic or neonatal lethality. Because of its mitochondrial location, 
SOD2 is the principal defense against the toxicity of superoxide generated by oxidative 
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phosphorylation in mitochondria. The SOD2-deficient phenotype is associated with 
pathologic evidence of mitochondrial injury and oxidative damage to biomolecules, as well 
as severe damage to cardiac muscle. Hematopoietic stem cell-specific SOD2-deficient mice 
were generated by transplantation of SOD2-deficient mouse HSCs, and sideroblastic 
anemia-like symptom was the major phenotype in the transplanted animals (Friedman et al., 
2001). This model suggests that oxidative stress in mitochondria affects the reduced heme 
biogenesis and accumulation of iron deposits in erythroid cells, and plays an important role 
in the pathogenesis of sideroblastic anemia.  
It is interesting to note that peroxiredoxin II (Prx II), a member of the thioredoxin peroxidase 
family, was decreased in SOD2-deficient cells, but showed an increase with antioxidant 
treatment (Friedman et al., 2004). Knockout of Prx II causes hemolytic anemia (Lee et al., 
2003) with evidence of increased oxidative damage to mature RBCs. This suggests that Prx II 
may be an important target of oxidative damage in SOD2-deficient cells. These findings 
suggest that mitochondrial dysfunction with excessive ROS production and with excess iron 
accumulation plays a critical role in causing SA. 
6. Therapeutic supplementation of antioxidant for anemia 
6.1 N-acetylcysteine (NAC) and its derivatives 
N-acetylcysteine (NAC) is one of the precursors of GSH. In vitro and animal studies have 
demonstrated that treatment of blood cells with NAC increases the intracellular 
concentration of the reduced form of GSH and decreases oxidative stress (Amer et al., 2006; 
Nur et al., 2011). Treatment of sickle cell patients with NAC at a dose of 2,400 mg per day 
increased intracellular GSH and reduced dense cell formation (Pace et al., 2003). NAC is also 
effective for antioxidant enzyme-deficient mice. Administration of NAC (1.0% in drinking 
water) to SOD1-deficient mice significantly suppressed ROS in erythrocytes and partly 
improved the anemia (Iuchi et al., 2007). 
Recently, several new derivatives of NAC have been developed. Among these new agents, 
the amide form of NAC, N-acetylcysteine amide (AD4), in which the carboxylic group is 
neutralized, is more lipophilic and has better membrane permeability than NAC. AD4 is 
also effective for its antioxidant effects. In vitro treatment of blood cells from ǃ thalassemic 
patients with AD4 elevated the reduced glutathione (GSH) content of erythrocytes, platelets, 
and polymorphonuclear leukocytes, and reduced their ROS. These effects resulted in 
significantly reduced sensitivity of thalassemic erythrocytes to hemolysis and phagocytosis 
by macrophages. Intra-peritoneal injection of AD4 to ǃthalassemic mice reduced the 
parameters of oxidative stress. The superiority of AD4, compared with NAC, in reducing 
oxidative stress markers in thalassemic cells both in vitro and in vivo has been 
demonstrated (Amer, J. et al., 2008). 
6.2 Vitamin E 
Vitamin E, a fat-soluble antioxidant, has been identified as an essential erythropoietic factor for 
certain species of animals. Treatment with vitamin E increased the number of colony forming 
units of erythroid precursors, enhanced erythropoiesis, and thus corrected the experimentally 
induced anemia in an animal model. Results of some of clinical trials suggested that vitamin E 
might prevent some types of human anemia due to its putative role in promoting 
erythropoiesis, enhancing the stability of erythrocyte membrane proteins and lipids, and 
reducing oxidative stress-induced erythrocyte injury. Supplementation of vitamin E was tried 
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for patients with some types of inherited hemolytic anemia. Some of these trials have shown 
that there was an improvement in hemolysis, as evidenced by longer erythrocyte lifespan, in 
elevated hemoglobin level, and decreased reticulocyte count (Corash et al., 1980; Hafez et al., 
1986). On the other hand, some groups indicated no change in hematologic status after 
treatment with high doses of vitamin E (Newman et al., 1979; Johnson et al., 1983). 
In patients suffering from homozygous ǃ thalassemia, supplementation of vitamin E was 
effective in reducing plasma levels of lipid peroxidation end products and a significant 
improvement in the hemoglobin levels (Das et al., 2004). A 4- to 8-week-long 
supplementation with vitamin E given to children with various types of thalassemia was 
shown to decrease H2O2-mediated erythrocyte hemolysis and increase the resistance to 
oxidative damage. Supplementation with vitamin E in children suffering from sickle cell 
anemia was shown to reduce the percentage of sickled erythrocytes, increased resistance of 
erythrocytes to lysis, and enhanced blood hemoglobin concentration (Jilani & Iqbal, 2011). 
7. Conclusion 
In recent years, many studies have implicated oxidative stress in anemia complicated with 
some infectious diseases. For example, malaria infection results in decreased antioxidant 
enzymes and substances such as catalase, GPx, SOD, GSH, ascorbate, and plasma 
tocopherol. The development of new antioxidant drugs with a function based on ROS 
reduction might constitute a promising tool not only for hereditary anemia but also for the 
control of the infection-mediated anemia. 
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